Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA.
Orimo
S
S
Department of Neurology, Kanto Central Hospital, Tokyo, Japan. orimos1@pp.iij4u.or.jp
Ozawa
E
E
Oka
T
T
Nakade
S
S
Tsuchiya
K
K
Yoshimoto
M
M
Wakabayashi
K
K
Takahashi
H
H
D019797:3-Iodobenzylguanidine / Q000493:pharmacokinetics*; D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000473:pathology*; D009206:Myocardium / Q000473:pathology*; D010300:Parkinson Disease / Q000473:pathology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D019797:3-Iodobenzylguanidine; D014446:Tyrosine 3-Monooxygenase